Ephedrine Dosage

Applies to the following strengths: 50 mg/mL; 25 mg; 50 mg; sulfate 5 mg/mL; 5 mg/mL-NaCl 0.9%; hydrochloride; 50 mg/10 mL-NaCl 0.9%; 50 mg/5 mL-NaCl 0.9%; 25 mg/5 mL-NaCl 0.9% preservative-free; sulfate; 4.7 mg/mL; 100 mg/10 mL-NaCl 0.9%; 10 mg/mL-NaCl 0.9%; 12.5 mg

Usual Adult Dose for Adams-Stokes Syndrome

Parenteral:

IM or subcutaneous: 25 mg to 50 mg IM or subcutaneously
IV: 5 mg to 25 mg IV administered slowly, may repeat in 5 to 10 minutes if necessary

Comments:

This product has not been found by the US FDA to be safe and effective and the product labeling has not been approved.

Uses: For use in Stokes-Adams syndrome with complete heart block; as a central nervous system (CNS) stimulant in narcolepsy and depressive states; and in patients with myasthenia gravis

Usual Adult Dose for Depression

Parenteral:

IM or subcutaneous: 25 mg to 50 mg IM or subcutaneously
IV: 5 mg to 25 mg IV administered slowly, may repeat in 5 to 10 minutes if necessary

Comments:

This product has not been found by the US FDA to be safe and effective and the product labeling has not been approved.

Uses: For use in Stokes-Adams syndrome with complete heart block; as a central nervous system (CNS) stimulant in narcolepsy and depressive states; and in patients with myasthenia gravis

Usual Adult Dose for Myasthenia Gravis

Parenteral:

IM or subcutaneous: 25 mg to 50 mg IM or subcutaneously
IV: 5 mg to 25 mg IV administered slowly, may repeat in 5 to 10 minutes if necessary

Comments:

This product has not been found by the US FDA to be safe and effective and the product labeling has not been approved.

Uses: For use in Stokes-Adams syndrome with complete heart block; as a central nervous system (CNS) stimulant in narcolepsy and depressive states; and in patients with myasthenia gravis

Usual Adult Dose for Narcolepsy

Parenteral:

IM or subcutaneous: 25 mg to 50 mg IM or subcutaneously
IV: 5 mg to 25 mg IV administered slowly, may repeat in 5 to 10 minutes if necessary

Comments:

This product has not been found by the US FDA to be safe and effective and the product labeling has not been approved.

Uses: For use in Stokes-Adams syndrome with complete heart block; as a central nervous system (CNS) stimulant in narcolepsy and depressive states; and in patients with myasthenia gravis

Usual Adult Dose for Hypotension

Akovaz(TM):

Initial dose: 5 mg to 10 mg IV bolus; administer additional boluses as needed, not to exceed a total dosage of 50 mg

Comments:

Must be diluted prior to administration.
Adjust dosage according to blood pressure goal (i.e., titrate to effect).

Use: For the treatment of clinically important hypotension occurring in the setting of anesthesia

Parenteral:

IM or subcutaneous: 25 mg to 50 mg IM or subcutaneously
IV: 5 mg to 25 mg IV administered slowly, may repeat in 5 to 10 minutes if necessary

Comments:

This product has not been found by the US FDA to be safe and effective and the product labeling has not been approved.

Use: For use as a pressor agent, particularly for the treatment of hypotension occurring during spinal anesthesia

Usual Adult Dose for Asthma - Acute

Parenteral:

IM or subcutaneous: 25 mg to 50 mg IM or subcutaneously
IV: 5 mg to 25 mg IV administered slowly, may repeat in 5 to 10 minutes if necessary

Comments:

This product has not been found by the US FDA to be safe and effective and the product labeling has not been approved.

Oral:

Initial dose: 12.5 mg to 25 mg orally every 4 hours
Maximum dose: 150 mg/day

Comments:

Most over the counter drugs are not reviewed and approved by the US FDA, however they may be marketed if they comply with applicable regulations and policies; the US FDA has not evaluated whether this product complies.

Use: For the temporary relief of shortness of breath, tightness of chest, and wheezing due to bronchial asthma